Thomas Velinder has extensive work experience in the pharmaceutical and contract research organizations (CRO) industry. Thomas has held various positions in business development, sales, and consulting.
In 2022, Thomas joined TFS HealthScience as a Business Development & Sales professional. Prior to this, in 2021, they founded and owned CRO Business Development Consulting, where they worked as a Consultant.
From 2021 to 2021, they served as a Senior Director of Business Development at Labcorp Drug Development. In the same year, they held the position of Senior Director of Business Development at Covance.
Thomas began their career in 1993 at AstraZeneca, where they held multiple roles, including Marketing Company President, Slovakia, Marketing Director, and Sales Manager.
Thomas has also worked at ICON Clinical Research as the Director of Business Development and at Fairchild Executive Search AB as a Regional Director.
Additionally, Thomas has experience in independent pharmaceutical consulting and served as the CEO of Hamlet Pharma AB.
Overall, Thomas Velinder has a diverse background in business development, sales, and leadership roles within the pharmaceutical industry.
Thomas Velinder attended Lund University from 1977 to 1984, where they successfully obtained a MSc degree in Law. In 2004, they briefly enrolled at INSEAD to study Finance for General Management. No specific degree was mentioned for this program.
This person is not in any teams
This person is not in any offices